Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCF1 | P14598 | 10/20 | 0.64 |
| ▸ | BACE1 | P56817 | 2/20 | 0.64 |
| ▸ | ACHE | P22303 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | GLA | P06280 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | CASP1 | P29466 | 2/20 | 0.54 |
| ▸ | CASP7 | P55210 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.54 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.54 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.54 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.54 |
| ▸ | NQO2 | P16083 | 1/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | DRD1 | P21728 | 1/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29690490 | 1.00 | NCF1 (0.64) | NCF1BACE1ACHEKDM4EALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL27826163 | 0.84 | BACE1 (0.57) | NCF1BACE1ACHEKDM4EALDH1A1 | |
| SCHEMBL28159979 | 0.82 | BACE1 (0.58) | NCF1BACE1ACHEKDM4EALDH1A1 | |
| SCHEMBL28107175 | 0.80 | NCF1 (0.46) | NCF1BACE1ACHEKDM4EALDH1A1 | |
| SCHEMBL1848398 | 0.78 | NCF1 (0.60) | NCF1BACE1ACHEKDM4EALDH1A1 | |
| SCHEMBL1845376 | 0.78 | NCF1 (0.60) | NCF1BACE1ACHEKDM4EALDH1A1 | |
| SCHEMBL482375 | 0.78 | BACE1 (0.60) | NCF1BACE1ACHEKDM4EALDH1A1 | |
| SCHEMBL1845788 | 0.78 | NCF1 (0.60) | NCF1BACE1ACHEKDM4EALDH1A1 | |
| SCHEMBL3094768 | 0.78 | BACE1 (1.00) | NCF1BACE1ACHEKDM4EALDH1A1 | |
| SCHEMBL31667822 | 0.78 | BACE1 (0.60) | NCF1BACE1ACHEKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110449178-B | Photocatalyst, preparation method and application thereof | 广州大学 | 2022-05-24 | — | — | CN | claimed |
| CN-110449178-A | A kind of photochemical catalyst, preparation method and its application | UNIV GUANGZHOU | 2019-11-15 | — | — | CN | claimed |
| CN-109641886-A | bicyclic BET bromodomain inhibitors and uses thereof | 康威基内有限公司 | 2019-04-16 | — | — | CN | claimed |
| EP-3220912-A1 | TLR INHIBITOR AND BRUTON'S TYROSINE KINASE INHIBITOR COMBINATIONS | Pharmacyclics LLC (US) | 2017-09-27 | — | — | EP | claimed |
| CN-107207463-A | Quinoline derivatives for the treatment of inflammatory diseases | ABIVAX公司 | 2017-09-26 | — | — | CN | claimed |
| WO-2016081460-A1 | TLR INHIBITOR AND BRUTON'S TYROSINE KINASE INHIBITOR COMBINATIONS | PHARMACYCLICS LLC (US) | 2016-05-26 | — | — | WO | claimed |
| CN-101056877-B | Imidazoquinoline compounds | NOVARTIS VACCINES & DIAGNOSTIC | 2010-06-09 | — | — | CN | claimed |
| CN-101056877-A | Imidazoquinoline compounds | NOVARTIS VACCINES & DIAGNOSTIC (US) | 2007-10-17 | — | — | CN | claimed |
| EP-1797091-A2 | IMIDAZOQUINOLINE COMPOUNDS | Novartis Vaccines and Diagnostics, Inc. (US) | 2007-06-20 | — | — | EP | claimed |
| WO-2006031878-A2 | IMIDAZOQUINOLINE COMPOUNDS | NOVARTIS VACCINES AND DIAGNOSTICS INC. (US) | 2006-03-23 | — | — | WO | claimed |
| WO-2024074559-A1 | COMBINATION OF SUBSTITUTED 2,4 DIAMINO-QUINOLINE COMPOUNDS AND MEK INHIBITORS FOR USE IN THE TREATMENT OF LIVER CANCERS | GENOSCIENCE PHARMA (FR) | 2024-04-11 | — | — | WO | disclosed |
| US-20230348574-A1 | RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2023-11-02 | — | — | US | disclosed |
| EP-4218799-A1 | RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME | GlaxoSmithKline Biologicals S.A. (BE) | 2023-08-02 | — | — | EP | disclosed |
| EP-4218800-A1 | RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME | GlaxoSmithKline Biologicals S.A. (BE) | 2023-08-02 | — | — | EP | disclosed |
| CN-113845548-B | Platinum complex of quinazoline hydrazine dithioformate and preparation method and application thereof | 深圳大学 | 2023-06-06 | — | — | CN | disclosed |
| EP-0175641-B1 | PROCESS FOR THE PREPARATION OF DIMETHYLMALEIC ANHYDRIDE | CIBA-GEIGY AG (CH) | 1988-02-24 | — | — | EP | disclosed |
| US-4644069-A | HEATING MALEIC ACID OR ANHYDRIDE WITH AN AMIDINE OR ITS SALT | CIBA-GEIGY CORPORATION (US) | 1987-02-17 | — | — | US | disclosed |
| US-4639531-A | HETEROCYCLIC AMIDINE CATALYST | CIBA-GEIGY CORPORATION (US) | 1987-01-27 | — | — | US | disclosed |
| EP-0175641-A1 | Process for the preparation of dimethylmaleic anhydride | CIBA-GEIGY AG (CH) | 1986-03-26 | — | — | EP | disclosed |
| EP-0174272-A1 | Process for the preparation of dimethylmaleic anhydride | CIBA-GEIGY AG (CH) | 1986-03-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348574-A1 | RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME | RNASEL, TIMCC, RNGTT | NCF1 554/4885BACE1 2485/4885ACHE 4528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.